Jiro Fujimoto

Author PubWeight™ 78.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol 2008 3.27
2 Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol 2002 2.61
3 A novel 3D hepatectomy simulation based on liver circulation: application to liver resection and transplantation. Hepatology 2005 1.97
4 Impact of preoperative planning using virtual segmental volumetry on liver resection for hepatocellular carcinoma. World J Surg 2007 1.35
5 ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth. J Cell Sci 2004 1.34
6 Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 2005 1.33
7 Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma. Cancer 2003 1.32
8 Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut 2006 1.31
9 LATS2-Ajuba complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during mitosis. FEBS Lett 2006 1.30
10 Coexpression of Gas6/Axl in human ovarian cancers. Oncology 2004 1.23
11 Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis. Am J Physiol Gastrointest Liver Physiol 2007 1.15
12 Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse. J Exp Med 2004 1.12
13 Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation. Nat Med 2008 1.09
14 Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings. J Hepatol 2007 1.06
15 Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model. Hepatology 2003 1.04
16 Phosphorylation of highly conserved neurofilament medium KSP repeats is not required for myelin-dependent radial axonal growth. J Neurosci 2009 1.04
17 Involvement of BREK, a serine/threonine kinase enriched in brain, in NGF signalling. Genes Cells 2004 1.00
18 The impact of 3-D virtual hepatectomy simulation in living-donor liver transplantation. J Hepatobiliary Pancreat Surg 2006 1.00
19 Contribution of TIR domain-containing adapter inducing IFN-beta-mediated IL-18 release to LPS-induced liver injury in mice. J Hepatol 2009 0.99
20 Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice. Hepatology 2013 0.96
21 Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers. BMC Cancer 2009 0.96
22 Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice. J Hepatol 2006 0.95
23 Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women. Steroids 2003 0.94
24 Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers. J Steroid Biochem Mol Biol 2007 0.94
25 Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers. J Biomed Sci 2007 0.93
26 Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int 2002 0.91
27 Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes. Am J Pathol 2005 0.91
28 Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats. Am J Pathol 2007 0.90
29 Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis. Gut 2006 0.90
30 Hepatocyte growth factor improves survival after partial hepatectomy in cirrhotic rats suppressing apoptosis of hepatocytes. Surgery 2008 0.90
31 Hemodynamic analysis and treatment of an enlarging extrahepatic portal aneurysm: report of a case. Surg Today 2014 0.90
32 Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma. Surg Today 2005 0.90
33 New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. J Gastroenterol 2013 0.89
34 Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model. Am J Physiol Gastrointest Liver Physiol 2004 0.88
35 Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20. Pancreas 2009 0.88
36 Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway. Lab Invest 2011 0.87
37 Role of innate immune response in liver regeneration. J Gastroenterol Hepatol 2007 0.87
38 Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci 2010 0.87
39 Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease. J Rheumatol 2003 0.87
40 Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers. Gynecol Oncol 2009 0.87
41 Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease. Arthritis Res Ther 2006 0.86
42 TLRs, NF-κB, JNK, and Liver Regeneration. Gastroenterol Res Pract 2010 0.86
43 Laparoscopic management of giant splenic true cyst with partial splenectomy: a case report. Asian J Endosc Surg 2013 0.86
44 The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice. Gastroenterol Res Pract 2010 0.85
45 Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count. Hepatol Res 2013 0.85
46 Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation. Blood 2004 0.85
47 Primary squamous cell carcinoma of the liver: an uncommon finding in contrast-enhanced ultrasonography imaging. Case Rep Gastroenterol 2011 0.85
48 Safety of hepatic resection for hepatocellular carcinoma in obese patients with cirrhosis. Surg Today 2013 0.85
49 c-Jun N-terminal kinase activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of retinoic acid receptor α protein in hepatic cells. Cancer Sci 2011 0.84
50 Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Sci 2003 0.84
51 Strategy of gene therapy for liver cirrohosis and hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2003 0.84
52 Minimally invasive laparoscopic liver resection: 3D MDCT simulation for preoperative planning. J Hepatobiliary Pancreat Surg 2009 0.84
53 Adeno-associated virus vector-mediated production of hepatocyte growth factor attenuates liver fibrosis in mice. Hepatol Int 2007 0.83
54 Angiogenesis is crucial for liver regeneration after partial hepatectomy. Surgery 2012 0.83
55 Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene. FEBS Lett 2012 0.83
56 Hepatocyte growth factor gene transfer with naked plasmid DNA ameliorates dimethylnitrosamine-induced liver fibrosis in rats. Hepatol Res 2008 0.83
57 Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers. Oncology 2008 0.82
58 Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers. Gynecol Oncol 2004 0.82
59 Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis. Hepatol Res 2011 0.82
60 Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers. Cancer Lett 2006 0.82
61 Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers. Cancer Sci 2003 0.82
62 Granulocyte-colony stimulating factor-producing gallbladder carcinoma. Int Surg 2014 0.81
63 Successful liver resection for biliary atresia with intrahepatic biliary cysts after Kasai procedure. J Pediatr Surg 2005 0.80
64 Reactive oxygen species modify oligosaccharides of glycoproteins in vivo: a study of a spontaneous acute hepatitis model rat (LEC rat). Biochem Biophys Res Commun 2006 0.80
65 Successful living related liver transplantation for adult Still's disease. J Gastroenterol Hepatol 2003 0.79
66 Hepatocyte growth factor promotes remodeling of murine liver fibrosis, accelerating recruitment of bone marrow-derived cells into the liver. Hepatol Res 2007 0.79
67 Frequent polymorphic changes but rare tumor specific mutations of the LATS2 gene on 13q11-12 in esophageal squamous cell carcinoma. Int J Oncol 2002 0.79
68 Multivariate logistic regression analysis for prediction of clinically relevant pancreatic fistula in the early phase after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 2013 0.79
69 Primary epithelioid hemangioendothelioma of the retroperitoneum: report of a case. Surg Today 2012 0.79
70 Randomized Controlled Trial of Pancreaticojejunostomy versus Stapler Closure of the Pancreatic Stump During Distal Pancreatectomy to Reduce Pancreatic Fistula. Ann Surg 2016 0.79
71 Sectionectomy of the liver. J Hepatobiliary Pancreat Sci 2012 0.78
72 Solitary mediastinal metastasis of hepatocellular carcinoma treated by video-assisted thoracic surgery: report of a case. Gen Thorac Cardiovasc Surg 2012 0.78
73 Role of inhibitor of DNA binding-1 protein is related to angiogenesis in the tumor advancement of uterine endometrial cancers. Exp Ther Med 2010 0.78
74 Role of c-kit receptor tyrosine kinase-mediated signal transduction in proliferation of bile epithelial cells in young rats after ligation of bile duct: a study using Ws/Ws c-kit mutant rats. J Hepatol 2003 0.77
75 Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers. Oncol Rep 2007 0.77
76 Treating liver cirrhosis in dogs with hepatocyte growth factor gene therapy via the hepatic artery. J Hepatobiliary Pancreat Surg 2009 0.77
77 Transfection of NF-kappaB decoy oligodeoxynucleotides into macrophages reduces murine fatal liver failure after excessive hepatectomy. J Surg Res 2008 0.77
78 In vivo effect of imatinib on progression of cecal GIST-like tumors in exon 17-type c-kit knock-in mice. Lab Invest 2009 0.77
79 Expression of E26 transformation specific (ETS-1) related to angiogenesis in ovarian endometriosis. Fertil Steril 2004 0.76
80 Hepatic effects of influxed endothelin-1 from portal vein: in situ portal vein infusion model using dogs. J Hepatobiliary Pancreat Surg 2006 0.76
81 Granulocyte colony-stimulating factor-producing cholangiocellular carcinoma. Int Surg 2015 0.75
82 Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers. BMC Cancer 2008 0.75
83 Delayed arterial hemorrhage after pancreaticoduodenectomy. Int Surg 2014 0.75
84 Parenteral nutrition administration leads to specific alterations in the expression of adipocytokines and peroxisome proliferator-activated receptors in a rat model. JPEN J Parenter Enteral Nutr 2011 0.75
85 Salvage treatment of laparoscopic cholecystectomy-associated bile duct stenosis combining laparoscopic and endoscopic procedures: a case report. Asian J Endosc Surg 2013 0.75
86 Impact of donor age on the growth of young recipient rats after liver transplantation. Surg Today 2006 0.75
87 Prediction of Postoperative Hepatic Failure after Liver Resection for Hepatocellular Carcinoma: Significance of the Aspartate Aminotransferase-to-Platelet Ratio Index. Hepatogastroenterology 2014 0.75
88 [Gene therapy for hepatocellular carcinoma]. Nihon Rinsho 2005 0.75
89 Sex steroids in uterine endometrial cancers. Horm Mol Biol Clin Investig 2011 0.75
90 Quantitative analysis of estrogen receptor proteins in rat ovary. J Steroid Biochem Mol Biol 2005 0.75
91 Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease. Am J Physiol Gastrointest Liver Physiol 2007 0.75
92 Effects of various steroids on platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA expression in uterine endometrial cancer cells. J Steroid Biochem Mol Biol 2003 0.75
93 Hepatic venoplasty to overcome outflow block in living related liver transplantation. J Pediatr Surg 2004 0.75
94 Development of hepatocellular carcinoma in cardiac congestive liver fibrosis: report of a case. Clin J Gastroenterol 2015 0.75
95 Primary adenocarcinoma of the minor duodenal papilla with mass-forming chronic pancreatitis: report of a case. Surg Today 2014 0.75
96 Perioperative and Long-term Outcome of the Warshaw Technique in Laparoscopic Spleen-preserving Distal Pancreatectomy. Surg Laparosc Endosc Percutan Tech 2017 0.75
97 Non-B non-C Hepatocellular Carcinoma: the Risk Factors for Recurrence and the Types of Recurrence Following Hepatic Resection. Hepatogastroenterology 2014 0.75
98 Regional hepatic regeneration after liver resection correlates well with preceding changes in the regional portal circulation in humans. Dig Dis Sci 2013 0.75
99 Angiomyolipoma of the liver presenting a homogeneously hypoechoic mass. J Gastroenterol 2005 0.75
100 Analysis of unique liver volume restoration after laparoscopic fenestration of liver cysts. Asian J Endosc Surg 2014 0.75
101 Outcomes of hepatic resection for large hepatocellular carcinoma: special reference to postoperative recurrence. Am Surg 2015 0.75